Supplements
Supplement: Keys to success with today’s presbyopia and toric lens technologies

Conducted for the sixth time at the 39th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), the 2020 ESCRS Clinical Trends Survey comprised 145 questions and received responses from nearly 400 doctors. In terms of trends in the use of intraocular lenses (IOLs) in routine practice, survey responses suggested that implantation of presbyopia-correcting IOLs during cataract surgery has remained stable over the past five years. However, in the same period, the use of toric IOLs during cataract procedures has doubled from 7% to 14% (Figure 1). Interestingly, survey respondents reported that if ‘cost were not an issue’, 38% of patients with clinically significant astigmatism would receive a toric IOL. In regions where reimbursement is available for toric IOLs, such as Australia, the reported use of these lenses is much greater (60–70%).
Tags: presbyopia and toric lens
Latest Articles
Simulators Benefit Surgeons and Patients
Helping young surgeons build confidence and expertise.
How Many Surgeries Equal Surgical Proficiency?
Internet, labs, simulators, and assisting surgery all contribute.
Improving Clinical Management for nAMD and DME
Global survey data identify barriers and opportunities.
Are Postoperative Topical Antibiotic Drops Still Needed?
Cataract surgeons debate the benefits of intracameral cefuroxime prophylaxis.
Emerging Technology for Detecting Subclinical Keratoconus
Brillouin microscopy shows promise in clinical studies.
Knowing Iris Repair: Modified Trifold Technique
Part eight of our series covers the modified trifold technique for large iris defects.
It’s All About Biomechanics!
Increasing the pool of patients eligible for refractive surgery.
Uncovering More Safe and Quick Options
Different strategies, such as PresbyLASIK, can offer presbyopes good outcomes.
Topography-Guided PRK for Keratoconus
Improving visual acuity in patients with keratoconus.
Defining AMD Treatment Protocol
Treatments trending to fewer injections for better results.